Vericel to Present at Upcoming Investor Conferences

Rhea-AI Summary

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for sports medicine and severe burn care, announced its participation in upcoming investor conferences. The company will present at the Credit Suisse 29th Annual Healthcare Conference on November 9, 2020, at 2:45 PM EST, and at the Stifel 2020 Virtual Healthcare Conference on November 16, 2020, at 2:40 PM EST. A live webcast will be available on the company's Investor Relations website.

CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced presentations at the following upcoming investor conferences.

• The Credit Suisse 29^th Annual Healthcare Conference on Monday, November 9^th at 2:45pm EST
• The Stifel 2020 Virtual Healthcare Conference on Monday, November 16^th at 2:40pm EST

A live webcast of the presentations will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com.

About Vericel Corporation
Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI^® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel^® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The company also holds an exclusive license for North American rights to NexoBrid^®, a registration-stage biological orphan product for debridement of severe thermal burns. For more information, please visit the company’s website at www.vcel.com.

Epicel^® and MACI^® are registered trademarks of Vericel Corporation. NexoBrid^® is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. © 2020 Vericel Corporation. All rights reserved.

Investor Contacts:
Lee Stern
Solebury Trout
lstern@troutgroup.com 
+1 646-378-2922

FAQ

What conferences is Vericel Corporation attending in November 2020?

Vericel Corporation will present at the Credit Suisse 29th Annual Healthcare Conference on November 9, 2020, and the Stifel 2020 Virtual Healthcare Conference on November 16, 2020.

What time will Vericel present at the Credit Suisse Conference?

Vericel will present at the Credit Suisse 29th Annual Healthcare Conference at 2:45 PM EST on November 9, 2020.

How can I watch Vericel's presentations live?

You can watch Vericel's presentations live via webcast on their Investor Relations website.

When is the Stifel 2020 Virtual Healthcare Conference?

The Stifel 2020 Virtual Healthcare Conference is scheduled for November 16, 2020.

What is the stock symbol for Vericel Corporation?

Vericel Corporation's stock symbol is VCEL.